Combination Study of Urelumab and Rituximab in Patients With B-cell Non-Hodgkins Lymphoma

PHASE1CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
B-Cell Malignancies
Interventions
BIOLOGICAL

Urelumab

BIOLOGICAL

Rituximab

Trial Locations (15)

11065

Memorial Sloan Kettering Cancer Center, New York

19104

Hospital Of The University Of Pennsylvania, Philadelphia

22908

University Of Virginia School Of Medicine, Charlottesville

28204

Levine Cancer Institute, Charlotte

33136

University Of Miami Sylvester Comprehensive Cancer Center, Miami

33140

Mount Sinai Comprehensive Cancer Center, Miami Beach

48109

University Of Michigan Health System, Ann Arbor

48201

Karmanos Cancer Institute, Detroit

52242

University Of Iowa Hospitals And Clinics, Iowa City

77030

The University Of Texas Md Anderson Cancer Center, Houston

90095

Ucla Department Of Medicine, Los Angeles

94305

Stanford University Medical Center, Stanford

97213

Providence Cancer Center Oncology And Hematology Care- Eastside, Portland

02215

Dana Faber Cancer Institute, Boston

07601

John Theurer Cancer Center, Hackensack

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY